Effect of estrogenic perturbations on δ-aminolevulinic acid-induced porphobilinogen deaminase and protoporphyrin IX levels in rat Harderian glands, liver, and R3230AC tumors

Biochemical Pharmacology

Volumn 58, Issue 11, 1999, Pages 1821-1829

  Gibson, Scott L ^a   Anderson, Linda T ^a   Havens, James J ^a   Hilf, Russell ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

aminolevulinic acid; Photodynamic therapy; Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID; ESTROGEN; PORPHOBILINOGEN DEAMINASE; PROTOPORPHYRIN; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; ESTROGEN ACTIVITY; FEMALE; HARDER GLAND; NONHUMAN; OVARIECTOMY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RODENT;

AMINOLEVULINIC ACID; ANIMALS; DISEASE MODELS, ANIMAL; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; HARDERIAN GLAND; HYDROXYMETHYLBILANE SYNTHASE; LIVER; MAMMARY NEOPLASMS, EXPERIMENTAL; OVARIECTOMY; PHOTOCHEMOTHERAPY; PROTOPORPHYRINS; RATS; RATS, INBRED F344; TAMOXIFEN;

EID: 0032723623     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00267-1     Document Type: Article

References (33)

1. Malik Z., Lugaci H. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. Br J Cancer. 56:1987;589-595.
2. Kennedy J.C., Pottier R.H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 14:1992;275-292.
3. Peng Q., Warloe T., Berg K., Moan J., Kongshaug M., Giercksky K.E., Nesland J.M. 5-Aminolevulinic acid-based photodynamic therapy. Cancer. 79:1997;2282-2308.
4. del C Batlle A.M. Porphyrins, porphyrias, cancer and photodynamic therapy - A model for carcinogenesis. J Photochem Photobiol B. 20:1993;5-22.
5. Regula J., MacRobert A.J., Gorchein A., Buonaccorsi G.A., Thorpe S.M., Spencer G.M., Hatfield A.R.W., Bown S.G. Photosensitization and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5-aminolaevulinic acid induced protoporphyrin IX - A pilot study. Gut. 36:1995;67-75.
6. Kriegmair M., Baumgartner R., Lumper W., Waidelich R., Hofstetter A. Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. Br J Urol. 77:1996;667-671.
7. Ades I.Z. Heme production in animal tissues The regulation of biogenesis of δ-aminolevulinate synthase . Int J Biochem. 22:1990;565-578.
8. Abraham N.G. Molecular regulation - Biological role of heme in hematopoiesis. Blood Rev. 5:1991;19-28.
9. Dailey H.A., Smith A. Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase. Biochem J. 223:1984;441-445.
10. Fritsch C., Batz J., Bolsen K., Shulte K.W., Zumdick M., Ruzicka T., Goerz G. Ex vivo application of δ-aminolevulinic acid induces high and specific porphyrin levels in human skin tumors Possible basis for selective photodynamic therapy . Photochem Photobiol. 66:1997;114-118.
11. Waidelich R., Hofstetter A., Stepp H., Baumgartner R., Weineger E., Kriegmair M. Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of upper tract urothelial tumors. J Urol. 159:1998;401-404.
12. Tope W.D., Ross E.V., Kolliar N., Martin A., Gillier R., Anderson R.R. Protoporphyrin IX fluorescence induced in basal cell carcinoma by oral δ-aminolevulinic acid. Photochem Photobiol. 67:1998;249-255.
13. Payne A.P. The harderian gland A tercentennial review . J Anat. 185:1994;1-49.
14. Rehorck S.J. Squamate Harderian gland An overview . Anat Rec. 248:1997;301-306.
15. Nagai M., Nagai T., Yamamoto M., Goto K., Bishop T.R., Hayashi N., Kondo H., Seyama Y., Kano K., Fujita H., Sassa S. Novel regulation of δ-aminolevulinate synthase in the rat Harderian gland. Biochem Pharmacol. 53:1997;643-650.
16. Holley A., King L.J., Gibbs A.H., De Matteis F. Strain and sex differences in the response of mice to drugs that induce protoporphyria Role of porphyrin biosynthesis and removal . J Biochem Toxicol. 5:1990;175-182.
17. Thompson G.G., Hordovatzi X., Moore M.R., McGadey J., Payne A.P. Sex differences in haem biosynthesis and porphyrin content in the Harderian gland of the golden hamster. Int J Biochem. 16:1984;849-852.
18. Payne A.P., McGadey J., Moore M.R., Thompson G. Androgenic control of the Harderian gland in the male golden hamster. J Endocrinol. 75:1977;73-82.
19. Gibson S.L., Cupriks J.D., Havens J.J., Nguyen M.L., Hilf R. A regulatory role for porphobilinogen deaminase (PBGD) in δ-aminolevulinic acid (δ-ALA)-induced photosensitization? Br J Cancer. 77:1998;235-243.
20. Gibson S.L., Havens J.J., Nguyen M.L., Hilf R. δ-Aminolevulinic acid-induced photodynamic therapy inhibits protoporphyrin IX biosynthesis and reduces subsequent treatment efficacy in vitro. Br J Cancer. 80:1999;998-1004.
21. Beru N., Goldwasser E. The regulation of heme biosynthesis during erythropoietin-induced erythroid differentiation. J Biol Chem. 260:1985;9251-9257.
22. Hilf R., Michel I., Bell C., Freeman J.J., Borman A. Biochemical and morphological properties of a new lactating tumor line in the rat. Cancer Res. 25:1965;286-299.
23. Grandchamp B., Phung N., Grelier M., Nordmann Y. The spectrophotometric determination of uroporphyrinogen I synthetase activity. Clin Chim Acta. 70:1976;113-118.
24. Hua Z., Gibson S.L., Foster T.H., Hilf R. Effectiveness of δ-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. Cancer Res. 55:1995;1723-1731.
25. Rick H., Sroka R., Stepp H., Kriegmair M., Huber R.M., Jacob K., Baumgartner R. Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood. J Photochem Photobiol B. 40:1997;313-319.
26. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
27. Rizzardini M., Smith A.G. Sex differences in the metabolism of hexachlorobenzene by rats and the development of porphyrias in females. Biochem Pharmacol. 31:1982;3543-3548.
28. Tofilon P.J., Piper W.N. Inhibition of rat testicular heme synthesis and depression of microsomal P-450 by estradiol benzoate. Biochem Pharmacol. 31:1982;3667-3671.
29. Galbraith R.A., Jellinck P.H. Cobalt-protoporphyrin, a synthetic heme analogue, feminizes hepatic androgen metabolism in the rat. J Steroid Biochem. 32:1989;421-426.
30. Marr F.A., Shah S.W., McGadey J., Moore M.R., Houston T., Payne A.P. The effects of bromocriptine and prolactin on porphyrin biosynthesis in the Harderian gland of the male hamster, Mesocritecus auratus. J Comp Physiol B. 164:1995;524-529.
31. Momma T., Hamblin M.R., Hasan T. Hormonal modulation of the accumulation of 5-aminolevulinic acid-induced protoporphyrin and photoxicity in prostate cancer cells. Int J Cancer. 72:1997;1062-1069.
32. Yang J.Z., Van Vugt D.A., Kennedy J.C., Reid R.L. Intrauterine 5-aminolevulinic acid induces selective fluorescence and photodynamic ablation of the rat endometrium. Photochem Photobiol. 57:1993;803-807.
33. Roy B.N., Van Vugt D.A., Weagle G.E., Pottier R.H., Reid R.L. Effect of 5-aminolevulinic acid dose and estrogen on protoporphyrin IX concentrations in the rat uterus. J Soc Gynecol Investig. 4:1997;40-46.